4.5 Review

Integrins and the activation of latent transforming growth factor beta 1 - An intimate relationship

期刊

EUROPEAN JOURNAL OF CELL BIOLOGY
卷 87, 期 8-9, 页码 601-615

出版社

ELSEVIER GMBH, URBAN & FISCHER VERLAG
DOI: 10.1016/j.ejcb.2008.01.012

关键词

cell contraction; fibrosis; matrix compliance; matrix metalloproteinase (MMP); latency-associated protein (LAP); latent TGF-beta 1-binding protein (LTBP-1)

资金

  1. Swiss National Science Foundation [3100A0-102150/1, 3100A0-113733/1]
  2. Gebert Ruf Stiftung
  3. Service Academique
  4. EPFL
  5. Competence Centre For Materials Science and Technology (CCMX) of the ETH Board, Switzerland

向作者/读者索取更多资源

Integrins are crucial for the ability of cells to sense mechanical perturbations and to transmit intracellular stress to their environment. We here review the more recently discovered role of integrins in activating the pleiotrophic cytokine transforming growth factor beta 1 (TGF-beta 1). TGF-beta 1 controls tissue homeostasis in embryonic and normal adult tissues and contributes to the development of fibrosis, cancer, autoimmune and vascular diseases when being mis-regulated. In most of these conditions, active TGF-beta 1 is generated by dissociation from a large latent protein complex that sequesters latent TGF-beta 1 in the extracellular matrix (ECM). Two main models are proposed how integrins contribute to latent TGF-beta 1 activation: (1) In a protease-dependent mechanism, integrins alpha v beta 8 and alpha v beta 3 are Suggested to simultaneously bind the latent TGF-beta 1 complex and proteinases. This close vicinity at the cell surface improves enzymatic cleavage of the latent complex to release active TGF-beta 1. (2) Integrins alpha v beta 3, alpha v beta 5, alpha v beta 6, and alpha v beta 8 appear to change the conformation of the latent TGF-beta 1 complex by transmitting cell traction forces. This action requires association of the latent complex with a mechanically resistant ECM and is independent from proteolysis. Understanding that different integrins use different mechanisms to activate latent TGF-beta 1 opens new possibilities to develop cell-specific therapeutic strategies for TGF-beta 1-induced pathologies. (C) 2008 Elsevier GmbH. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据